News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News Stories for 2015 Shelley Wood December 29, 2015
News Opinion Editor's Corner Las 10 Noticias de TCTMD Más Leídas de 2015 Shelley Wood December 29, 2015
News Daily News Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement Michael O'Riordan December 27, 2015
News Daily News La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar Michael O'Riordan December 27, 2015
News Daily News BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History Michael O'Riordan December 27, 2015
News Daily News Bajar la Presión Arterial Reduce el Riesgo Vascular con Independencia de la Presión Arterial Basal y los Antecedentes Patológicos Michael O'Riordan December 27, 2015
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News Por 1ª Vez unos Estudios asocian las Bacterias Intestinales a la Aterosclerosis y ofrecen una Mirada Asombrosa a una Nueva Diana Farmacológica Michael O'Riordan December 21, 2015
News Daily News Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target Michael O'Riordan December 21, 2015
News Daily News Revisión de las Métricas de Rendimiento para el Uso de Estatinas Post-IM, Post-PCI en Pacientes EAC Michael O'Riordan December 20, 2015
News Daily News Radial-Access Associated with One-Third Less Bleeding in Rescue PCI After Fibrinolysis Michael O'Riordan December 20, 2015
News Daily News Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients Michael O'Riordan December 20, 2015
News Industry News AtriCure Announces the First Patient Enrolled in International Afib Study December 16, 2015
News Daily News Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV Michael O'Riordan December 15, 2015
News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015